Boundless Bio, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLD and other ETFs, options, and stocks.About BOLD
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F.
CEOZachary D. Hornby
CEOZachary D. Hornby
Employees64
Employees64
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2018
Founded2018
Employees64
Employees64
BOLD Key Statistics
Market cap26.42M
Market cap26.42M
Price-Earnings ratio-0.43
Price-Earnings ratio-0.43
Dividend yield—
Dividend yield—
Average volume143.37K
Average volume143.37K
High today—
High today—
Low today—
Low today—
Open price$1.23
Open price$1.23
Volume0.00
Volume0.00
52 Week high$3.12
52 Week high$3.12
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
The current Boundless Bio, Inc.(BOLD) stock price is $1.14, with a market capitalization of 26.42M. The stock trades at a price-to-earnings (P/E) ratio of -0.43.
On 2026-01-02, Boundless Bio, Inc.(BOLD) stock opened at $1.23, reached a high of —, and a low of —.
Boundless Bio, Inc.(BOLD) shares are trading with a volume of 0, against a daily average of 143.37K.
In the last year, Boundless Bio, Inc.(BOLD) shares hit a 52-week high of $3.12 and a 52-week low of $1.00.
In the last year, Boundless Bio, Inc.(BOLD) shares hit a 52-week high of $3.12 and a 52-week low of $1.00.
People also own
Based on the portfolios of people who own BOLD. This list is generated using Robinhood data, and it’s not a recommendation.